The firm is building an antibody-based immune system-related protein biomarker test for stroke diagnosis in both community and academic hospitals.
The grant is the second in the last six months that the Paul G. Allen Family Foundation has awarded to Chembio for diagnostics development.
The virus, known as HPgV-2, was detected in blood samples from individuals with concurrent hepatitis C virus infections.
The sensor features a DNA-based steric hindrance method, and can detect the presence of antibodies in whole blood in less than 10 minutes.
Researchers used arrays with more than 175,000 peptides matching sections of the Chagas pathogen proteome to characterize novel elements of the immune response to infection.
Three collaborators will further explore the clinical usefulness of a TAA panel in early cancer detection and measuring response to cancer immunotherapy.
NEW YORK (GenomeWeb) – Agilent Technologies' Dako business said today that it will develop a companion diagnostic test for a cancer drug being developed by Merck.
The Center for Personalized Cancer Therapy is a joint program with the Dana-Farber/Harvard Cancer Center.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.